  Deciphering regulatory events that drive malignant transformation represents
a major challenge for systems biology. Here we analyzed genome-wide
transcription profiling of an in-vitro transformation process. We focused on a
cluster of genes whose expression levels increased as a function of p53 and
p16INK4A tumor suppressors inactivation. This cluster predominantly consists of
cell cycle genes and constitutes a signature of a diversity of cancers. By
linking expression profiles of the genes in the cluster with the dynamic
behavior of p53 and p16INK4A, we identified a promoter architecture that
integrates signals from the two tumor suppressive channels and that maps their
activity onto distinct levels of expression of the cell cycle genes, which in
turn, correspond to different cellular proliferation rates. Taking components
of the mitotic spindle as an example, we experimentally verified our
predictions that p53-mediated transcriptional repression of several of these
novel targets is dependent on the activities of p21, NFY and E2F. Our study
demonstrates how a well-controlled transformation process allows linking
between gene expression, promoter architecture and activity of upstream
signaling molecules.
